Review



hif-1 alpha antibody (h1alpha67)  (Bio-Techne corporation)


Bioz Verified Symbol Bio-Techne corporation is a verified supplier
Bioz Manufacturer Symbol Bio-Techne corporation manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Bio-Techne corporation hif-1 alpha antibody (h1alpha67)
    Hif 1 Alpha Antibody (H1alpha67), supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 96/100, based on 1127 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nb100-105/HIF-1+alpha+Antibody+(H1alpha67)/custom%40nb100-105%4010%2E21203%2Frs%2E3%2Ers-9960398%2Fv1
    Average 96 stars, based on 1127 article reviews
    hif-1 alpha antibody (h1alpha67) - by Bioz Stars, 2026-10
    96/100 stars

    Images

    Related Articles

    other:

    Article Title: HIF1α and HIF2α immunoreactivity in epithelial tissue of primary and recurrent pterygium by immunohistochemical analysis.
    Article Snippet: bating the slides in 0.3% H2O2 for 15 min. Sections were incubated for 15 min (anti-HIF1α) and 60 min (antiHIF2α) at room temperature followed by an overnight incubation with the primary antibodies anti-HIF1α (clone H1alpha67 Novus Biologicals, Inc., Littleton, CO; 1:8000 dilution) and anti-HIF2α (clone 190b; Santa Cruz Biotechnology, Inc., Dallas, TX; 1:500 dilution) at 4 °C. Secondary antibody was applied for 60 min. Sections were incubated for



    Similar Products

    96
    Bio-Techne corporation hif-1 alpha antibody (h1alpha67)
    Hif 1 Alpha Antibody (H1alpha67), supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nb100-105/HIF-1+alpha+Antibody+(H1alpha67)/custom%40nb100-105%4010%2E21203%2Frs%2E3%2Ers-9960398%2Fv1
    Average 96 stars, based on 1 article reviews
    hif-1 alpha antibody (h1alpha67) - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    96
    Novus Biologicals hif1a
    Mapping transcriptional regulation of Matk in neuropeptide neurons. a Chromatin accessibility signals indicating transcriptional regulation landscapes across three groups, highlighting different gene regions of Matk with precise locus positions. b A schematic diagram illustrating binding sites of five TFs within the regulatory loci for the gene Matk . c Interaction network for Matk and its TFs. Two repressors (blue; Nfib, Arnt) were consistent with reduced Matk accessibility and expression after CFA injection, while three activators (red; <t>Hif1a,</t> Bhlhe40, Smad5) opposed the repression and promoted partial recovery with TB treatment. d A cross-group analysis correlates gene expression patterns (snRNA-seq) with chromatin enrichment profiles (snATAC-seq). TSS, transcription start site. CON, saline + vehicle; CFA, CFA +vehicle; TB, CFA + tributyrin
    Hif1a, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nb100-105/HIF-1+alpha+Antibody+(H1alpha67)/pmc13090343-277-25-26
    Average 96 stars, based on 1 article reviews
    hif1a - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    96
    Novus Biologicals nb100
    Mapping transcriptional regulation of Matk in neuropeptide neurons. a Chromatin accessibility signals indicating transcriptional regulation landscapes across three groups, highlighting different gene regions of Matk with precise locus positions. b A schematic diagram illustrating binding sites of five TFs within the regulatory loci for the gene Matk . c Interaction network for Matk and its TFs. Two repressors (blue; Nfib, Arnt) were consistent with reduced Matk accessibility and expression after CFA injection, while three activators (red; <t>Hif1a,</t> Bhlhe40, Smad5) opposed the repression and promoted partial recovery with TB treatment. d A cross-group analysis correlates gene expression patterns (snRNA-seq) with chromatin enrichment profiles (snATAC-seq). TSS, transcription start site. CON, saline + vehicle; CFA, CFA +vehicle; TB, CFA + tributyrin
    Nb100, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nb100-105/HIF-1+alpha+Antibody+(H1alpha67)/pm41811850-255-35-33
    Average 96 stars, based on 1 article reviews
    nb100 - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    96
    Novus Biologicals hif 1α antibody
    PAARH <t>recruits</t> <t>HIF-1α</t> to CD47 promoters and activates CD47 transcription. A CUT&RUN analysis of HIF-1α binding to CD47 promoter in SNU-398 cells with PAARH overexpression or control cultured under hypoxia. B CUT&RUN analysis of HIF-1α binding to CD47 promoter in HCCLM3 cells with PAARH knockdown or control cultured under hypoxia. C CUT&RUN analysis of HIF-1α binding to CD47 promoter in CHL-1 cells with PAARH overexpression or control cultured under hypoxia. D CUT&RUN analysis of HIF-1α binding to CD47 promoter in SW620 cells with PAARH knockdown or control cultured under hypoxia. E Luciferase activity in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. F Luciferase activity in HCCLM3 cells with PAARH knockdown or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. G Luciferase activity in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. H Luciferase activity in SW620 cells with PAARH knockdown or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. I Luciferase activity in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs and luciferase reporters containing CD47 promoter. J Luciferase activity in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs and luciferase reporters containing CD47 promoter. For E-J, results are shown as the relative ratio of firefly luciferase activity to renilla luciferase activity. K qPCR analysis of CD47 mRNA expression in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. L Flow cytometry quantification of CD47 protein expression in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. M qPCR analysis of CD47 mRNA expression in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. N Flow cytometry quantification of CD47 protein expression in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. Data are shown as mean ± SD of n = 3 biological replicates. ** p < 0.01, *** p < 0.001, **** p < 0.0001, ns, not significant, by Student’s t -test (A, C, E, G) or one-way ANOVA with Dunnett’s multiple comparisons test (B, D, F, H-N)
    Hif 1α Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nb100-105/HIF-1+alpha+Antibody+(H1alpha67)/pmc13085390-46-24-29
    Average 96 stars, based on 1 article reviews
    hif 1α antibody - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    96
    Novus Biologicals press nb100
    PAARH <t>recruits</t> <t>HIF-1α</t> to CD47 promoters and activates CD47 transcription. A CUT&RUN analysis of HIF-1α binding to CD47 promoter in SNU-398 cells with PAARH overexpression or control cultured under hypoxia. B CUT&RUN analysis of HIF-1α binding to CD47 promoter in HCCLM3 cells with PAARH knockdown or control cultured under hypoxia. C CUT&RUN analysis of HIF-1α binding to CD47 promoter in CHL-1 cells with PAARH overexpression or control cultured under hypoxia. D CUT&RUN analysis of HIF-1α binding to CD47 promoter in SW620 cells with PAARH knockdown or control cultured under hypoxia. E Luciferase activity in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. F Luciferase activity in HCCLM3 cells with PAARH knockdown or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. G Luciferase activity in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. H Luciferase activity in SW620 cells with PAARH knockdown or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. I Luciferase activity in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs and luciferase reporters containing CD47 promoter. J Luciferase activity in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs and luciferase reporters containing CD47 promoter. For E-J, results are shown as the relative ratio of firefly luciferase activity to renilla luciferase activity. K qPCR analysis of CD47 mRNA expression in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. L Flow cytometry quantification of CD47 protein expression in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. M qPCR analysis of CD47 mRNA expression in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. N Flow cytometry quantification of CD47 protein expression in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. Data are shown as mean ± SD of n = 3 biological replicates. ** p < 0.01, *** p < 0.001, **** p < 0.0001, ns, not significant, by Student’s t -test (A, C, E, G) or one-way ANOVA with Dunnett’s multiple comparisons test (B, D, F, H-N)
    Press Nb100, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nb100-105/HIF-1+alpha+Antibody+(H1alpha67)/pm41803892-74-11-13
    Average 96 stars, based on 1 article reviews
    press nb100 - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    96
    Novus Biologicals anti hif 1α
    PAARH <t>recruits</t> <t>HIF-1α</t> to CD47 promoters and activates CD47 transcription. A CUT&RUN analysis of HIF-1α binding to CD47 promoter in SNU-398 cells with PAARH overexpression or control cultured under hypoxia. B CUT&RUN analysis of HIF-1α binding to CD47 promoter in HCCLM3 cells with PAARH knockdown or control cultured under hypoxia. C CUT&RUN analysis of HIF-1α binding to CD47 promoter in CHL-1 cells with PAARH overexpression or control cultured under hypoxia. D CUT&RUN analysis of HIF-1α binding to CD47 promoter in SW620 cells with PAARH knockdown or control cultured under hypoxia. E Luciferase activity in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. F Luciferase activity in HCCLM3 cells with PAARH knockdown or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. G Luciferase activity in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. H Luciferase activity in SW620 cells with PAARH knockdown or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. I Luciferase activity in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs and luciferase reporters containing CD47 promoter. J Luciferase activity in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs and luciferase reporters containing CD47 promoter. For E-J, results are shown as the relative ratio of firefly luciferase activity to renilla luciferase activity. K qPCR analysis of CD47 mRNA expression in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. L Flow cytometry quantification of CD47 protein expression in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. M qPCR analysis of CD47 mRNA expression in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. N Flow cytometry quantification of CD47 protein expression in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. Data are shown as mean ± SD of n = 3 biological replicates. ** p < 0.01, *** p < 0.001, **** p < 0.0001, ns, not significant, by Student’s t -test (A, C, E, G) or one-way ANOVA with Dunnett’s multiple comparisons test (B, D, F, H-N)
    Anti Hif 1α, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nb100-105/HIF-1+alpha+Antibody+(H1alpha67)/pmc12702999-420-0-11
    Average 96 stars, based on 1 article reviews
    anti hif 1α - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    Image Search Results


    Mapping transcriptional regulation of Matk in neuropeptide neurons. a Chromatin accessibility signals indicating transcriptional regulation landscapes across three groups, highlighting different gene regions of Matk with precise locus positions. b A schematic diagram illustrating binding sites of five TFs within the regulatory loci for the gene Matk . c Interaction network for Matk and its TFs. Two repressors (blue; Nfib, Arnt) were consistent with reduced Matk accessibility and expression after CFA injection, while three activators (red; Hif1a, Bhlhe40, Smad5) opposed the repression and promoted partial recovery with TB treatment. d A cross-group analysis correlates gene expression patterns (snRNA-seq) with chromatin enrichment profiles (snATAC-seq). TSS, transcription start site. CON, saline + vehicle; CFA, CFA +vehicle; TB, CFA + tributyrin

    Journal: International Journal of Oral Science

    Article Title: Single-cell multi-omics sequencing reveals cell-specific transcriptomic and chromatin accessibility profiles in gut microbiome metabolite butyrate-produced pain modulation

    doi: 10.1038/s41368-026-00432-9

    Figure Lengend Snippet: Mapping transcriptional regulation of Matk in neuropeptide neurons. a Chromatin accessibility signals indicating transcriptional regulation landscapes across three groups, highlighting different gene regions of Matk with precise locus positions. b A schematic diagram illustrating binding sites of five TFs within the regulatory loci for the gene Matk . c Interaction network for Matk and its TFs. Two repressors (blue; Nfib, Arnt) were consistent with reduced Matk accessibility and expression after CFA injection, while three activators (red; Hif1a, Bhlhe40, Smad5) opposed the repression and promoted partial recovery with TB treatment. d A cross-group analysis correlates gene expression patterns (snRNA-seq) with chromatin enrichment profiles (snATAC-seq). TSS, transcription start site. CON, saline + vehicle; CFA, CFA +vehicle; TB, CFA + tributyrin

    Article Snippet: For validating TF-produced chromatin accessibility regulation of target genes, we performed ChIP with antibodies against predicted TFs: Thap11 (Santa Cruz, sc-517366), Hinfp (Santa Cruz, sc-373855), Hif1a (Novus, NB100-105), or Yy1 (Santa Cruz, sc-7341), and binding regions of Nop14 , Matk , Idh3b , Ndst2 , and Tomm6 were analyzed by qPCR with the respective primers (Supplementary Table ).

    Techniques: Binding Assay, Expressing, Injection, Gene Expression, Saline

    Mapping transcriptional regulation of Tomm6 in OPCs. a Chromatin accessibility signals indicating transcriptional regulation landscapes across three groups, highlighting different gene regions of Tomm6 in OPCs with precise locus positions. b A schematic diagram illustrating binding sites of four TFs within the regulatory loci for the gene Tomm6 . c A dynamic interaction network of Tomm6 and its TFs. Two activators (red; Srebf2, Hif1a) promoted Tomm6 accessibility and expression following CFA injection, while two repressors (blue; Bhlhe41, Cebpd) were involved in normalization of Tomm6 accessibility and expression after TB treatment. TSS, transcription start site. CON, saline + vehicle; CFA, CFA +vehicle; TB, CFA + tributyrin

    Journal: International Journal of Oral Science

    Article Title: Single-cell multi-omics sequencing reveals cell-specific transcriptomic and chromatin accessibility profiles in gut microbiome metabolite butyrate-produced pain modulation

    doi: 10.1038/s41368-026-00432-9

    Figure Lengend Snippet: Mapping transcriptional regulation of Tomm6 in OPCs. a Chromatin accessibility signals indicating transcriptional regulation landscapes across three groups, highlighting different gene regions of Tomm6 in OPCs with precise locus positions. b A schematic diagram illustrating binding sites of four TFs within the regulatory loci for the gene Tomm6 . c A dynamic interaction network of Tomm6 and its TFs. Two activators (red; Srebf2, Hif1a) promoted Tomm6 accessibility and expression following CFA injection, while two repressors (blue; Bhlhe41, Cebpd) were involved in normalization of Tomm6 accessibility and expression after TB treatment. TSS, transcription start site. CON, saline + vehicle; CFA, CFA +vehicle; TB, CFA + tributyrin

    Article Snippet: For validating TF-produced chromatin accessibility regulation of target genes, we performed ChIP with antibodies against predicted TFs: Thap11 (Santa Cruz, sc-517366), Hinfp (Santa Cruz, sc-373855), Hif1a (Novus, NB100-105), or Yy1 (Santa Cruz, sc-7341), and binding regions of Nop14 , Matk , Idh3b , Ndst2 , and Tomm6 were analyzed by qPCR with the respective primers (Supplementary Table ).

    Techniques: Binding Assay, Expressing, Injection, Saline

    PAARH recruits HIF-1α to CD47 promoters and activates CD47 transcription. A CUT&RUN analysis of HIF-1α binding to CD47 promoter in SNU-398 cells with PAARH overexpression or control cultured under hypoxia. B CUT&RUN analysis of HIF-1α binding to CD47 promoter in HCCLM3 cells with PAARH knockdown or control cultured under hypoxia. C CUT&RUN analysis of HIF-1α binding to CD47 promoter in CHL-1 cells with PAARH overexpression or control cultured under hypoxia. D CUT&RUN analysis of HIF-1α binding to CD47 promoter in SW620 cells with PAARH knockdown or control cultured under hypoxia. E Luciferase activity in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. F Luciferase activity in HCCLM3 cells with PAARH knockdown or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. G Luciferase activity in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. H Luciferase activity in SW620 cells with PAARH knockdown or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. I Luciferase activity in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs and luciferase reporters containing CD47 promoter. J Luciferase activity in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs and luciferase reporters containing CD47 promoter. For E-J, results are shown as the relative ratio of firefly luciferase activity to renilla luciferase activity. K qPCR analysis of CD47 mRNA expression in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. L Flow cytometry quantification of CD47 protein expression in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. M qPCR analysis of CD47 mRNA expression in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. N Flow cytometry quantification of CD47 protein expression in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. Data are shown as mean ± SD of n = 3 biological replicates. ** p < 0.01, *** p < 0.001, **** p < 0.0001, ns, not significant, by Student’s t -test (A, C, E, G) or one-way ANOVA with Dunnett’s multiple comparisons test (B, D, F, H-N)

    Journal: Cancer Cell International

    Article Title: PAARH suppresses Kupffer cell phagocytosis to promote tumor liver metastasis by upregulating CD47

    doi: 10.1186/s12935-026-04251-0

    Figure Lengend Snippet: PAARH recruits HIF-1α to CD47 promoters and activates CD47 transcription. A CUT&RUN analysis of HIF-1α binding to CD47 promoter in SNU-398 cells with PAARH overexpression or control cultured under hypoxia. B CUT&RUN analysis of HIF-1α binding to CD47 promoter in HCCLM3 cells with PAARH knockdown or control cultured under hypoxia. C CUT&RUN analysis of HIF-1α binding to CD47 promoter in CHL-1 cells with PAARH overexpression or control cultured under hypoxia. D CUT&RUN analysis of HIF-1α binding to CD47 promoter in SW620 cells with PAARH knockdown or control cultured under hypoxia. E Luciferase activity in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. F Luciferase activity in HCCLM3 cells with PAARH knockdown or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. G Luciferase activity in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. H Luciferase activity in SW620 cells with PAARH knockdown or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. I Luciferase activity in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs and luciferase reporters containing CD47 promoter. J Luciferase activity in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs and luciferase reporters containing CD47 promoter. For E-J, results are shown as the relative ratio of firefly luciferase activity to renilla luciferase activity. K qPCR analysis of CD47 mRNA expression in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. L Flow cytometry quantification of CD47 protein expression in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. M qPCR analysis of CD47 mRNA expression in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. N Flow cytometry quantification of CD47 protein expression in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. Data are shown as mean ± SD of n = 3 biological replicates. ** p < 0.01, *** p < 0.001, **** p < 0.0001, ns, not significant, by Student’s t -test (A, C, E, G) or one-way ANOVA with Dunnett’s multiple comparisons test (B, D, F, H-N)

    Article Snippet: The binding of HIF-1α to CD47 promoter were evaluated by CUT&RUN assays using the CUT&RUN Assay Kit (Cell Signaling Technology, Danvers, MA, USA) and HIF-1α antibody (Cat. No. NB100-105; Novus, Saint Louis, MO, USA).

    Techniques: Binding Assay, Over Expression, Control, Cell Culture, Knockdown, Luciferase, Activity Assay, Transfection, Expressing, Flow Cytometry